ETAHX (ETAHX) Stock Price & Analysis
ETAHX (ETAHX) rose 2.14% to USD 47.19 as of June 10, 2026 at 19:55 UTC, according to Nexqual real-time market data.
ETAHX last closed at USD 46.2; the session ranged USD 47.19–47.19 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 32.22–52.23 (NAS). Source: Nexqual, June 10, 2026 at 19:55 UTC.
Key Statistics (as of June 10, 2026 at 19:55 UTC)
| Price | USD 47.19 |
|---|---|
| Change | ▲ 2.14% (up) |
| Previous Close | USD 46.2 |
| Open | USD 47.19 |
| Day Range | USD 47.19 – 47.19 |
| 52-Week Range | USD 32.22 – 52.23 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (ETAHX)
Nexqual's technical model rates ETAHX "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 19:55 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 40.78 (neutral) |
| vs SMA50 | Below (USD 49.55) |
| MACD | -0.78 (negative) |
Financial Health Score (ETAHX)
Nexqual rates ETAHX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 19:55 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ETAGX | Eventide Gilead Fund Class A | USD 60.6 | ▲ 0.61% |
| ETNHX | Eventide Healthcare & Life Scie | USD 47.61 | ▲ 2.15% |
| ETIHX | Eventide Healthcare & Life Scie | USD 48.93 | ▲ 2.15% |
| ETCHX | Eventide Healthcare & Life Scie | USD 42.39 | ▲ 2.14% |
| ETGLX | Eventide Gilead Fund | USD 61.17 | ▲ 0.63% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 19:55 UTC. This page is informational and not investment advice.